abstract |
The present invention relates to a novel imidazole derivative of formula (I) having an arylpiperidine substituent, a process for producing the same, and a pharmaceutical composition for preventing or treating MCH (melanin-concentrating hormone) -related diseases comprising the imidazole derivative as an active ingredient. . |